It will be very interesting to further investigate how ALDH1A1 is only activated by TAZ in CSCs and whether high levels of TAZ is positively correlated with those of ALDH1A1 (CSC-specific) in clinical lung cancer patients. This evidence concerns the gene WWTR1 and lung carcinoma.